Metforminassocieret laktatacidose kan behandles med kontinuerlig venovenøs hæmofiltration

Ugeskrift for Laeger

Volumn 174, Issue 23, 2012, Pages 1602-1603

  Jørgensen, Helene Korvenius ^a   Nielsen, Jane Stab ^a   Gilsaa, Torben ^a  

^a KOLDING HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; FEMALE; HEMOFILTRATION; HUMAN; LACTIC ACIDOSIS; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL REPLACEMENT THERAPY;

ACIDOSIS, LACTIC; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOFILTRATION; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

EID: 84864751486     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. www.medstat.dk (15. jun 2011 og 27. sept 2011).
2. Christiansen AL, Madsbad S. Virkningsmekanisme og effekt i mono- og kombinationsterapi på glukosestofskiftet ved type 2-diabetes. Ugeskr Læger 2002; 164:2025.
3. Vecchio S, Papa P, Protti A. Metformin and lactic acidosis. I: Vincent JL, red. Annual update in intensive care and emergency medicine. Heidelberg: Springer-Verlag, 2011:685-93.
4. Peters N, Jay N, Barraud D et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care 2008;12:R149.